4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-015363
Chief Commercial Officer bought 30,000 shares at $5.47 ($164,100)
From the SEC's structured data for this filing
Trades in this filing
Gayer Charles K · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-13 | Purchase : show line 1 in the form | +30,000 | $5.47 | $164,100 | 307,533 | D |
| Open-market purchases · 30,000 sh · avg $5.47 · $164,100 | ||||||
Loading xslF345X05/form4.xml…